CX3CR1 and inflammatory bowel disease: However, in the gut, CX3CR1-expressing mononuclear phagocytes modulate the composition of and respond to gut fungal communities in a CLR/SYK-dependent manner and patients with IBD carrying the CX3CR1-M280 polymorphism have reduced antifungal antibody responses [344].